E2a-Pbx1 Exhibited a Promising Prognosis in Pediatric Acute Lymphoblastic Leukemia Treated With the CCLG-ALL2008 Protocol

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s115257
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Pediatric Acute Lymphoblastic Leukemia

Hematology & Transfusion International Journal
2017English

Site-Specific Translocation and Evidence of Postnatal Origin of the T(1;19) E2a-Pbx1 Fusion in Childhood Acute Lymphoblastic Leukemia

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2002English

IKZF1 Deletion Is an Independent Predictor of Outcome in Pediatric Acute Lymphoblastic Leukemia Treated According to the ALL-BFM 2000 Protocol

Klinische Padiatrie
MedicineChild HealthPediatricsPerinatology
2011English

Association Between Nutritional Status and Outcome of Childhood Acute Lymphoblastic Leukemia Treated With Wijaya Kusuma Protocol

Paediatrica Indonesiana
2008English

miRNAs in Acute Lymphoblastic Leukemia: Diagnosis, Prognosis and Target Therapeutic

2019English

Cognitive Reserve and Brain Volumes in Pediatric Acute Lymphoblastic Leukemia

Brain Imaging and Behavior
Molecular NeuroscienceNuclear MedicineRadiologyCognitive NeuroscienceMental HealthNeurologyBehavioral NeuroscienceCellularPsychiatryImaging
2010English

The Origin of Relapse in Pediatric T-Cell Acute Lymphoblastic Leukemia

Haematologica
Hematology
2015English

A Single Institution's Experience With Cytogenetic and MRD Outcomes in Pediatric Acute Lymphoblastic Leukemia

Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
Medicine
2019English

Myeloid Sarcoma Presenting With Leukemoid Reaction in a Child Treated for Acute Lymphoblastic Leukemia

Case Reports in Hematology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy